I’ve been thinking about technical analysis (TA). Not so much how to do it, but more about what it actually is. Some of it can be tested scientifically, but a lot can’t (for more on this distinction refer to the excellent book by David Aronson, “Evidence-Based Technical Analysis: Applying the Scientific Method and Statistical Inference to Trading Signals”). So, TA isn’t science, but to therefore conclude it is art seems like giving up and going back to a lazy binary classification.
I found a paper that looks at the topic in an interesting way. “On the Analogy Between Scientific Study of Technical analysis and Ethnopharmacology” by Waldemar Stronka compares TA to folk-medicine. This comparison is interesting.
Ethnopharmacology is the study of traditional or folk remedies. Many of these remedies, initially discovered through trial and error, later became the basis for modern medicines like aspirin and ephedrine. The critical progression in ethnopharmacology, which could also be applied to TA, involves moving through three stages:
In the context of TA, most of the debate among economists and analysts remains stuck on the first point: “Does TA work?” This question, while important, only scratches the surface of what TA could be. Just as trial and error in traditional medicine eventually led to drugs we rely on today, the insights from TA—patterns, indicators, and signals—might hold underlying truths about market behavior that we are just beginning to explore scientifically. It’s entirely plausible that some of the methods used in TA do work, although not always for the reasons that practitioners claim. This alone warrants moving beyond the binary argument of “works or doesn’t” to a more refined discussion on why and how certain elements of TA function.
If we follow the ethnopharmacology analogy, the next logical step would be figuring out the mechanisms behind why some technical indicators work. This could involve connecting TA more firmly to fields like behavioral finance and quantitative analysis. Behavioral finance shows us that markets are driven by psychological forces—fear, greed, and herd behavior, among others—which could explain why certain patterns emerge repeatedly. For instance, the idea of support and resistance levels might reflect psychological price points where market participants are inclined to act, creating self-fulfilling prophecies. Likewise, quantitative analysis can help us refine these insights by subjecting them to rigorous testing and statistical validation, allowing us to identify when a signal is truly valuable and when it’s just noise.
However, there are significant challenges to advancing the study of TA in this way.
Despite these challenges, the analogy to ethnopharmacology offers a constructive framework. By accepting that some elements of TA likely do work, we can begin to study why they work. This approach would lead to a better understanding of the psychological and behavioral drivers of market movements and could help create a more evidence-based framework for TA. In the end, much like folk medicine, TA likely contains valuable insights that are not fully understood or appreciated today.
Disclaimer
This document does not constitute advice or a recommendation or offer to sell or a solicitation to deal in any security or financial product. It is provided for information purposes only and on the understanding that the recipient has sufficient knowledge and experience to be able to understand and make their own evaluation of the proposals and services described herein, any risks associated therewith and any related legal, tax, accounting, or other material considerations. To the extent that the reader has any questions regarding the applicability of any specific issue discussed above to their specific portfolio or situation, prospective investors are encouraged to contact HTAA or consult with the professional advisor of their choosing.
Except where otherwise indicated, the information contained in this article is based on matters as they exist as of the date of preparation of such material and not as of the date of distribution of any future date. Recipients should not rely on this material in making any future investment decision.
LEAVE A COMMENT